2014-05347. Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management.

ADDRESSES:

Submit written requests for copies of summaries of safety and effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.

FOR FURTHER INFORMATION CONTACT:

Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-796-6570.

SUPPLEMENTARY INFORMATION:

I. Background

In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from July 1, 2013, through September 30, 2013. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.

Table 1—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From July 1, 2013, Through September 30, 2013

PMA No., Docket No.	Applicant	Trade name	Approval date
P120022, FDA-2013-M-0851	QIAGEN Manchester Ltd	therascreen® EGFR RGQ PCR Kit	July 12, 2013.
P110002, FDA-2013-M-0987	LDR Spine USA, Inc	Mobi-C® Cervical Disc Prosthesis	August 7, 2013.
P120009, FDA-2013-M-0988	PFM Medical AG	Nit-Occlud® PDA	August 16, 2013.
P120004, FDA-2013-M-1017	Parascript, LLC	Parascript® Accu Detect® 6.1.0	August 22, 2013.
P110009, FDA-2013-M-1095	LDR Spine USA, Inc	Mobi-C® Cervical Disc Prosthesis	August 23, 2013.
P110040, FDA-2013-M-1159	Medtronic Vascular	Medtronic Vascular Complete® SE Vascular Stent System	September 19, 2013.
P120010, FDA-2013-M-1206	Medtronic, Inc	MiniMed 530G System	September 26, 2013.

II. Electronic Access

Persons with access to the Internet may obtain the documents at http://www.fda.gov/​MedicalDevices/​ProductsandMedicalProcedures/​DeviceApprovalsandClearances/​PMAApprovals/​default.htm.

Dated: March 6, 2014.

Leslie Kux,

Assistant Commissioner for Policy.